Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
Read More…
Industry, Sector and Symbol
Industry Holding & other investment offices
Sub-IndustryN/A
SectorMedical
Phone852-3605-8180
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$147.03 million
Profitability
Miscellaneous
Employees1,261
Next Earnings Date11/26/2019 (Estimated)
OptionableOptionable
Global Cord Blood (NYSE:CO) Frequently Asked Questions
What is Global Cord Blood's stock symbol?
Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."
How were Global Cord Blood's earnings last quarter?
Global Cord Blood Corp (NYSE:CO) issued its earnings results on Tuesday, August, 27th. The medical research company reported $0.13 EPS for the quarter. The medical research company earned $39.82 million during the quarter. Global Cord Blood had a return on equity of 9.60% and a net margin of 31.78%. View Global Cord Blood's Earnings History.
When is Global Cord Blood's next earnings date?
Has Global Cord Blood been receiving favorable news coverage?
Media headlines about CO stock have been trending negative this week, according to InfoTrie. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Global Cord Blood earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned news stories about the medical research company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Global Cord Blood.
Are investors shorting Global Cord Blood?
Global Cord Blood saw a drop in short interest during the month of August. As of August 31st, there was short interest totalling 222,400 shares, a drop of 14.7% from the July 31st total of 260,700 shares. Based on an average daily trading volume, of 62,700 shares, the days-to-cover ratio is currently 3.5 days. Currently, 0.6% of the shares of the company are sold short. View Global Cord Blood's Current Options Chain.
Who are some of Global Cord Blood's key competitors?
Some companies that are related to Global Cord Blood include Bain Capital Specialty Finance (BCSF), GS ACQUISITION /SH CL A (GSAH), HAYMAKER ACQUIS/SH CL A (HYAC), Trinity Merger (TMCX), Repay (RPAY), THUNDER BRDG AC/SH SH (TBRG), Pivotal Acquisition (PVT), FORUM MERGER II/SH CL A (FMCI), ANDINA ACQUISIT/SH SH (ANDA), AgroFresh Solutions (AGFS), KBL MERGER CORP/SH (KBLM), Pensare Acquisition (WRLS), Infrastructure and Energy Alternatives (IEA), SGOCO Group (SGOC) and HL Acquisition (HCCH).
What other stocks do shareholders of Global Cord Blood own?
Who are Global Cord Blood's key executives?
Global Cord Blood's management team includes the folowing people:
- Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 47)
- Mr. Albert Chen, CFO & Director (Age 43)
- Ms. Xin Xu, Chief Technology Officer (Age 65)
- Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 60)
- Ms. Cathy Bai, VP of Corp. Fin.
Who are Global Cord Blood's major shareholders?
Global Cord Blood's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.33%), Man Group plc (0.74%), Quinn Opportunity Partners LLC (0.21%), SG Americas Securities LLC (0.11%), Parametric Portfolio Associates LLC (0.08%) and Citadel Advisors LLC (0.02%). View Institutional Ownership Trends for Global Cord Blood.
Which institutional investors are selling Global Cord Blood stock?
Which institutional investors are buying Global Cord Blood stock?
CO stock was bought by a variety of institutional investors in the last quarter, including Man Group plc, Renaissance Technologies LLC, SG Americas Securities LLC, Parametric Portfolio Associates LLC and Quinn Opportunity Partners LLC. View Insider Buying and Selling for Global Cord Blood.
How do I buy shares of Global Cord Blood?
Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Global Cord Blood's stock price today?
One share of CO stock can currently be purchased for approximately $4.60.
How big of a company is Global Cord Blood?
What is Global Cord Blood's official website?
How can I contact Global Cord Blood?
Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]
MarketBeat Community Rating for Global Cord Blood (NYSE CO)
MarketBeat's community ratings are surveys of what our community members think about Global Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days.
